The management of end-stage heart failure and reducing the risk of cardiorenal syndrome
Paul Scully and David Goldsmith
DOI: https://doi.org/10.7861/clinmedicine.13-6-610
Clin Med December 2013 Paul Scully
King's Health Partners AHSC, Guy's and St Thomas' NHS Foundation Trust, London, UK
Roles: cardiology trainee;
David Goldsmith
King's Health Partners AHSC, Guy's and St Thomas' NHS Foundation Trust, London, UK
Roles: professor of cardiorenal medicine;
Article Information
vol. 13 no. 6 610-613
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online December 2, 2013.
Copyright & Usage:
© 2013 Royal College of Physicians
Author Information
- Paul Scully, cardiology trainee; and
- David Goldsmith, professor of cardiorenal medicine;⇑
- Address for correspondence: Dr D Goldsmith, King's Health Partners, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, Great Maze Pond, London SE1 9RT. E-mail: David.Goldsmith{at}gstt.nhs.uk
Article usage
Article Tools
The management of end-stage heart failure and reducing the risk of cardiorenal syndrome
Paul Scully, David Goldsmith
Clinical Medicine Dec 2013, 13 (6) 610-613; DOI: 10.7861/clinmedicine.13-6-610
Citation Manager Formats
Jump to section
- Article
- Introduction
- Epidemiology of chronic heart failure and chronic kidney disease
- Pathophysiology of cardio-renal syndrome type 2 focussing on coincident chronic kidney disease
- Management of chronic heart failure with chronic kidney disease
- Managing renal function while using chronic heart failure therapies
- Managing serum potassium while using chronic heart failure therapies
- Ultrafiltration
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.